Episode Summary
Executive Summary: The roundtable argues that growth is not dead, but the market has normalized: fewer deals, lower valuations, and more emphasis on real business quality, profitability, and alignment. The guests see an opening for IPOs and late-stage rounds, but only for companies with strong execution, durable growth, and rational pricing—not “crappy growth, high burn.”
Main Topics: Growth Is Not Dead, But the Market Has Normalized (Priority: 5/5): The investors argue that while deal volume is down sharply from 2021-22, underlying company growth remains strong and the market is moving back toward more realistic pacing and pricing. Valuation Reset and Incentive Alignment (Priority: 5/5): They discuss why down rounds and 409A resets can be healthy because they restore employee motivation and reduce distortion from inflated 2021 pricing, even if investors lose paper value. Structured Rounds and Misalignment Risk (Priority: 4/5): The panel is skeptical of structured terms like liquidation preferences or guaranteed returns when used to bridge valuation gaps, arguing they can distort founder incentives and block sensible exits. IPO Market Reopening and What It Signals (Priority: 5/5): They view recent IPOs as a positive sign, but emphasize that public-market performance will be driven by fundamentals and that IPOs are now often the late-stage valuation mechanism. Public Market Metrics: Growth vs Profitability (Priority: 4/5): The discussion shifts from pure revenue growth toward profitability, free cash flow, and the Rule of 40, reflecting a broader investor preference for durable economics. AI Is a Real Trend, But Valuations Are Frothy (Priority: 3/5): Both investors believe AI will have major long-term impact, but they warn that some AI valuations are ahead of fundamentals and will require caution. Late-Stage Growth, PE, and the Missing Market Segment (Priority: 4/5): The least active area is late-stage growth/pre-IPO investing; they expect opportunities for sponsors and growth funds in scaled software companies that are not ideal public or strategic targets.
Key Arguments: Growth in operating companies is still strong even though new investment pace is down dramatically versus 2021-22. The market is closer to reality today than in 2021, which should lead to better decisions and healthier long-term outcomes. Companies that raised large amounts of capital at peak valuations often do not need to raise again, which explains part of the slowdown. Down rounds or valuation resets can be beneficial because they restore employee incentives and avoid false pricing narratives. Structured financing can create bad incentives because founders may reject good exit offers if the structure only pays off at a much higher valuation. LPs and venture firms face a marking-to-market problem, since admitting valuation resets can hurt fundraising optics, but auditors and realism should prevail. The public market is now the main late-stage pricing mechanism for many companies, reducing the need for private pre-IPO rounds. The market is rewarding both growth and profitability, but the weighting has shifted materially toward efficiency and path to profitability. Public software multiples are below 2021 levels but not permanently broken; there is still upside from current levels if companies perform. AI will reshape software and operations broadly, but many AI deals are overpriced relative to near-term fundamentals.
Data Points: Tech IPO drought: About 1 year without any tech IPO - Used to argue that recent IPO activity is a meaningful reopening, not a full bubble Strategic M&A drought: About 1 year without meaningful large strategic M&A - Cisco’s acquisition of Splunk was cited as evidence of reopening Portfolio companies growing >50% YoY: 180 companies - Insight portfolio companies growing 50% in Q2 2023 vs Q2 2022 New investment pace: Dramatically lower in 2023 vs 2021-2022 - Growth deal volume has slowed materially though transactions still happen Typical fundraising cadence: 12-24 months - Used to explain why many 2021-22 funded companies may need capital again around 2024 Cash on balance sheet: $300M-$500M - Some portfolio companies raised enough capital earlier that they do not need to fundraise again soon Cash on balance sheet (other cases): $100M - Example of companies that raised at very high valuations and may not need to replicate them today Revenue scale of cited software deals: $100M+ ARR/business scale - Referenced as classic minority software investments still getting done Growth rate of a cited company: 50% - Example of a company growing fast but still burning a little cash Pre-IPO liquidity in recent IPOs: Less than 10% sold - Three recent IPOs were described as small-float offerings Public market correlation: Revenue multiple correlation to growth fell from ~72% to mid-30s - Illustrates shifting valuation focus from growth to profitability Rule of 40 expectations: Shifted from 60-70% growth / -20% to -30% EBITDA to roughly 30/10 or 20/20 - Shows how public investors now want both growth and profitability Long-term multiple contraction assumption in 2021 deals: ~50% - Growth investors underwrote major compression from peak levels Short interest: High / ‘off the chart’ - Suggested as a factor affecting post-IPO trading in small-float names AI fund allocation: 7%-8% of Fund 12 - Insight said this share was mostly invested in 2021 AI infrastructure companies AI investing in 2023: Almost zero - Insight said 2023 AI pricing was too high relative to fundamentals ARR example for fundability: $50M ARR, 50% growth, no burn - Used to discuss whether a non-AI SaaS company can still attract growth capital Clavio post-IPO stock discussion: ~20% to 40% upside debated over 12 months - A friendly bet on whether the stock trades up after IPO ARM market cap reference: $57B - Used as another example of public-market dynamics and AI/chip demand IPO sale size: 6%-8% of company - Referenced when discussing recent IPOs and why price discovery matters less when only a small stake is sold
Pivotal Quotes: "Growth is not dead." — Devin Parekh: Opening argument that underlying company growth remains strong despite a slowdown in new financings "I think those companies are not worth much if you don't have a team that's motivated." — Devin Parekh: Explaining why valuation resets and incentive realignment matter for long-term execution "If you buy crappy growth, high burn, like, don't need to email me." — Woody Marshall: A blunt summary of the type of growth assets the panel will avoid in the current market
Implications: For founders and investors, the message is clear: raise only when necessary, price realistically, and prioritize durable growth plus efficiency. The IPO window is reopening, but only companies with real fundamentals and aligned incentives are likely to win.